|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Stryker Corporation |
SYK |
863667101 |
231 |
$68,824.14 |
2.14% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$68,627.79 |
2.13% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$68,396.16 |
2.12% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$68,202.82 |
2.12% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$67,876.48 |
2.11% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$68,026.00 |
2.11% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$67,883.37 |
2.11% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$67,510.05 |
2.10% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$67,439.85 |
2.09% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$67,147.08 |
2.09% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$67,370.25 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$67,158.23 |
2.09% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$67,184.25 |
2.09% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$66,891.55 |
2.08% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$67,072.71 |
2.08% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$66,806.52 |
2.07% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$66,752.00 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$66,654.93 |
2.07% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,656.06 |
2.07% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$66,568.66 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$66,377.52 |
2.06% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$66,266.48 |
2.06% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$66,063.33 |
2.05% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$66,049.73 |
2.05% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$66,072.81 |
2.05% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$65,940.68 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
298 |
$66,147.06 |
2.05% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$65,899.86 |
2.05% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$65,648.73 |
2.04% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$65,824.05 |
2.04% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$65,309.13 |
2.03% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$65,344.80 |
2.03% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$65,502.22 |
2.03% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$65,410.18 |
2.03% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$65,271.83 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$65,403.18 |
2.03% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$64,713.45 |
2.01% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$64,832.05 |
2.01% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,482.00 |
2.00% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$63,712.50 |
1.98% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$63,636.39 |
1.98% |
| Waters Corporation |
WAT |
941848103 |
147 |
$63,837.69 |
1.98% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$63,566.82 |
1.97% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$62,976.82 |
1.96% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$62,640.10 |
1.95% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$61,743.50 |
1.92% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$59,423.49 |
1.85% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$53,562.91 |
1.66% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,528.67 |
1.38% |
| US Dollar |
$USD |
|
24,365 |
$24,365.40 |
0.76% |
| Danish Krone |
$DKK |
|
0 |
$0.00 |
0.00% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| Swiss Franc |
$CHF |
|
0 |
$0.00 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|